| payload |
{"created_at":"2026-04-14T12:12:32.185 {"created_at":"2026-04-14T12:12:32.185628+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/johnson-johnson-q1-profit-down-sales-rise-lifts-fy26-outlook","value":{"fp":"f74ff2cae08e23f6","kind":"unusual_volume","published_at":"2026-04-14T11:43:59+00:00","source":"Nasdaq Markets","summary":"(RTTNews) - Drug major Johnson & Johnson (JNJ), while reporting sharply lower first-quarter profit despite sales growth, on Tuesday lifted fiscal 2026 earnings and sales forecast for fiscal 2026. The company also announced higher quarterly dividend.","tickers":["JNJ"],"title":"Johnson & Johnson Q1 Profit Down, Sales Rise; Lifts FY26 Outlook","url":"https://www.nasdaq.com/articles/johnson-johnson-q1-profit-down-sales-rise-lifts-fy26-outlook"}}... |